Heart Failure NYHA Class II
Cardiovascular·MeSH: Heart Failure
Prevalence
1800.0 / 100K
Incidence
300.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Heart Failure NYHA Class II?
There are 1 clinical trial targeting Heart Failure NYHA Class II tracked by BioSniper.
What is the prevalence of Heart Failure NYHA Class II?
The estimated prevalence of Heart Failure NYHA Class II is approximately 1800.0 per 100,000 population.
Deep-dive into Heart Failure NYHA Class II
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis